AbstractHIVINTEREST 2020Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO StudyView Abstract
AbstractHIVINTEREST 2020A Hybrid Interpersonal Training Model to build Capacity for Health-Care-Providers (HITCH) to Manage Children, Adolescents and Adults on Third-Line Anti-Retro Viral (ART) Therapy in Uganda.View Abstract
AbstractHIVINTEREST 2020Effectiveness of male Strategy (MS) in HIV case identification and linkage of MLHIV to treatment in Cameroon.View Abstract
AbstractHIVINTEREST 2020Doing Index Testing differently: A health education approach for old clients returning for refill and those newly initiating ART to effectively participate in index testing.View Abstract
AbstractHIVINTEREST 2020Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: 96-week results of the ANRS 12313 – NAMSAL trialView Abstract
AbstractHIVINTEREST 2020Does Dolutegravir causes weight gain: a retrospective observational cohort study from Lusaka, ZambiaView Abstract
AbstractHIVINTEREST 2020DTG+3TC vs DTG+TDF/FTC (GEMINI-1&-2): Confirmed Virologic Withdrawals Through Week 96View Abstract
AbstractHIVINTEREST 2020Positive Effects of Intensified Preventive Calls/Home Visits on Early Retention Among Adults Newly Initiated on Antiretroviral Therapy in Zambézia Province, MozambiqueView Abstract
AbstractHIVINTEREST 2020Traditional healers can increase uptake of HIV testing among adults of unknown serostatus: results from a cluster randomized pilot study in southwestern UgandaView Abstract
AbstractHIVINTEREST 2020Current approaches for identifying and managing HIV treatment failure among children, adolescents, and young people in sub-Saharan Africa: Multi-country experience from the New Horizons CollaborativeView Abstract
AbstractHIVINTEREST 2020Association between DREAMS interventions and HIV risk behaviors of young women’s male sex partners in Rakai, UgandaView Abstract
